◆ 会议时间：2025年10月16-19日
◆ 会议地点：中国 武汉
◆ 会议简介：
2025年组织工程与再生医学国际学会亚太大会(TERMIS-AP 2025)将于2025年10月16-19日在中国武汉举行，会议由国际组织工程与再生医学学会(TERMIS)与韩国组织工程和再生医学学会联合组织。TERMIS亚太地区年会将汇集来自学术界和工业界的研究人员、科学家、临床医生、在训人员和学生代表，共同讨论该领域的前沿进展。
国际组织工程与再生医学学会(TERMIS)成立于2006年，其宗旨是在全球范围内促进组织工程与再生医学科学技术发展以提高知识水平，尽而改善全球患者的护理。TERMIS的会员资格向对组织工程和再生医学领域感兴趣宣并支持协会使命的个人开放。TERMIS在美洲、欧洲和亚太地区设有分会，旨在促进该地区组织工程和再生医学领域的教育和研究。未经许可禁止复制转载摘录本站任何内容-领域国际医学会议网。
TERMIS-AP Conference
Tissue Engineering and Regenerative Medicine International Society – Asia-Pacific Conference 2025
Date:
October 16-19, 2025
Venue:
中国光谷科技会展中心（CHINA OPTICS VALLEY CONVENTION & EXHIBITION CENTER）
Wuhan, China
Organized by：
Tissue Engineering and Regenerative Medicine International Society
摘要征文投稿：
The submission deadline is 6/15/2025, Sunday.
点此提交摘要>>>Submit Abstract>>>
For Abstract Authors
The TERMIS-AP 2025 conference, themed “New Era for Regenerative Medicine Translation”, is a pivotal event in the Asia-Pacific region, uniting a diverse community of researchers, clinicians, and industry leaders. Its primary goal is to accelerate the translation of regenerative medicine from bench to bedside. More than just a gathering, this conference serves as a catalyst for change, where we will collaboratively formulate the “Wuhan Consensus,” a definitive statement outlining the future direction of tissue engineering and regenerative medicine. Together, we aim to enhance healthcare by exchanging cutting-edge research and establishing progressive legal frameworks that support innovation in this field.
We warmly invite submissions not only of timely academic research findings but also insights from government officials, regulatory bodies, and industry professionals. Your contributions are vital to fostering the multifaceted discussions we seek to encourage at TERMIS-AP 2025. By incorporating perspectives from various sectors, we can more effectively tackle the complex challenges facing regenerative medicine. Your abstracts and presentations will significantly enrich the conference with real-world applications, regulatory insights, and innovative solutions from the industry. Your participation is crucial to this transformative journey as we collectively advance the field and make a meaningful impact on global healthcare.
Note: All abstract submitters, including presenting authors, are expected to pay their own travel expenses and conference registration fee(s).
Instructions For Authors
Please use the 2025 TERMIS-AP Abstract Template. The Abstract should contain:
Title: Choose a clear, on-point, concise title.
Abstract Body: The abstract text should be limited to 300 words and one page.
Figure or Table: The abstract may contain up to one figure or table to illustrate the key findings
Categories And Session Topics
When submitting abstracts, authors will be provided with a range of categories in Tissue Engineering and Regenerative Medicine. Please select the category that fits your work best:
- Regenerative Biomaterials
- Smart, responsive, or adaptive Biomaterials
- Bioenergetic-Active Materials
- Scaffolds and Matrices
- Biomaterials Design
- Natural Regenerative Materials-Silk, Collagen, Chitosan, etc.
- Biofabrication and Additive Manufacturing
- TERM-Enabling Technologies (i.e., Artificial Intelligence, Computational approaches)
- Stem Cell-based Regenerative Medicine Strategies
- Organoids, Micro-tissues, Organ-on-a-Chip, and In Vitro Models
- Engineered Organs
- Gene Editing and Gene Therapy in Regeneration
- Physical stimuli in Regenerative medicine
- Nanotechnology in Tissue Engineering
- Cancer Treatment and Tissue Regeneration
- Musculoskeletal System(Bone, cartilage, tendon, and muscles)
- Cardiovascular/Lymphatic System/Circulatory Health
- Vascular Materials and Regeneration
- Neural Tissue Engineering and Neuroregeneration
- Wound Healing and Skin Regeneration
- Ophthalmologic/Otorhinolaryngologic Tissue Engineering
- Respiratory, Urologic & Gastrointestinal
- Bioelectronics
- Immunoregulation
- Regulatory Science for TERM products-New Standards, New Tools, and New Approaches
- Regenerative Medicine Translation: Ethics, Policy, and Clinical Practices
◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
